ZA974428B - Antifungal composition with enhanced bioavailability. - Google Patents

Antifungal composition with enhanced bioavailability.

Info

Publication number
ZA974428B
ZA974428B ZA9704428A ZA974428A ZA974428B ZA 974428 B ZA974428 B ZA 974428B ZA 9704428 A ZA9704428 A ZA 9704428A ZA 974428 A ZA974428 A ZA 974428A ZA 974428 B ZA974428 B ZA 974428B
Authority
ZA
South Africa
Prior art keywords
antifungal composition
enhanced bioavailability
bioavailability
enhanced
antifungal
Prior art date
Application number
ZA9704428A
Other languages
English (en)
Inventor
Surendra A Sangekar
Ping I Lee
Winston A Vadino
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA974428B publication Critical patent/ZA974428B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA9704428A 1996-05-24 1997-05-21 Antifungal composition with enhanced bioavailability. ZA974428B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65532996A 1996-05-24 1996-05-24

Publications (1)

Publication Number Publication Date
ZA974428B true ZA974428B (en) 1997-11-24

Family

ID=24628452

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704428A ZA974428B (en) 1996-05-24 1997-05-21 Antifungal composition with enhanced bioavailability.

Country Status (28)

Country Link
EP (1) EP0914127B1 (pl)
JP (1) JP3366648B2 (pl)
KR (1) KR100307427B1 (pl)
CN (1) CN1121860C (pl)
AR (1) AR007250A1 (pl)
AT (1) ATE213632T1 (pl)
AU (1) AU719109B2 (pl)
BR (1) BR9711167A (pl)
CA (1) CA2255663C (pl)
CO (1) CO4840511A1 (pl)
CZ (1) CZ293586B6 (pl)
DE (1) DE69710729T2 (pl)
ES (1) ES2169440T3 (pl)
HK (1) HK1017855A1 (pl)
HU (1) HU221371B1 (pl)
ID (1) ID16956A (pl)
IL (1) IL126979A (pl)
MY (1) MY118988A (pl)
NO (1) NO316997B1 (pl)
NZ (1) NZ332699A (pl)
PE (1) PE68898A1 (pl)
PL (1) PL188401B1 (pl)
RU (1) RU2207119C2 (pl)
SK (1) SK281818B6 (pl)
TR (1) TR199802424T2 (pl)
TW (1) TW504390B (pl)
WO (1) WO1998007429A2 (pl)
ZA (1) ZA974428B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DK1413331T3 (da) * 2001-01-26 2007-12-10 Schering Corp Kombinationer af peroxisomproliferatoraktiveret receptor (PPAR)-aktivatoren fenofibrat og sterolabsorptionsinhibitoren ezetimib til vaskulære indikationer
WO2004066981A1 (en) * 2003-01-29 2004-08-12 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition containing metaxalone as active agent
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
SG190117A1 (en) 2010-11-01 2013-06-28 Rib X Pharmaceuticals Inc Pharmaceutical compositions
RU2450807C1 (ru) * 2011-05-11 2012-05-20 Общество с ограниченной ответственностью фирма "Вита" Стабилизированный фармацевтический состав с противогрибковым действием
CN103845292A (zh) * 2012-11-29 2014-06-11 正大天晴药业集团股份有限公司 泊沙康唑微丸及其制备方法
US9763934B2 (en) * 2014-03-05 2017-09-19 Professional Compounding Centers Of America Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
CZ294823B6 (cs) * 1993-12-21 2005-03-16 Schering Corporation Fungicidní tetrahydrofurany

Also Published As

Publication number Publication date
PE68898A1 (es) 1998-11-10
ES2169440T3 (es) 2002-07-01
CZ293586B6 (cs) 2004-06-16
MY118988A (en) 2005-02-28
BR9711167A (pt) 1999-08-17
TR199802424T2 (xx) 1999-03-22
DE69710729T2 (de) 2002-08-14
IL126979A0 (en) 1999-09-22
KR20000065222A (ko) 2000-11-06
HU221371B1 (en) 2002-09-28
SK281818B6 (sk) 2001-08-06
AR007250A1 (es) 1999-10-27
HUP9904265A3 (en) 2000-05-29
HK1017855A1 (en) 1999-12-03
PL330480A1 (en) 1999-05-24
CA2255663A1 (en) 1998-02-26
AU719109B2 (en) 2000-05-04
WO1998007429A3 (en) 1998-04-23
NZ332699A (en) 2000-01-28
JP3366648B2 (ja) 2003-01-14
CN1121860C (zh) 2003-09-24
ID16956A (id) 1997-11-27
CA2255663C (en) 2002-08-20
AU5939998A (en) 1998-03-06
CO4840511A1 (es) 1999-09-27
TW504390B (en) 2002-10-01
RU2207119C2 (ru) 2003-06-27
NO985447D0 (no) 1998-11-23
ATE213632T1 (de) 2002-03-15
NO316997B1 (no) 2004-07-19
IL126979A (en) 2000-10-31
NO985447L (no) 1998-11-23
CZ379098A3 (cs) 1999-03-17
JP2000509720A (ja) 2000-08-02
WO1998007429A2 (en) 1998-02-26
SK160898A3 (en) 1999-05-07
DE69710729D1 (de) 2002-04-04
CN1228699A (zh) 1999-09-15
HUP9904265A2 (hu) 2000-04-28
EP0914127A2 (en) 1999-05-12
KR100307427B1 (ko) 2001-12-28
EP0914127B1 (en) 2002-02-27
PL188401B1 (pl) 2005-01-31

Similar Documents

Publication Publication Date Title
CY2434B1 (en) Antifungal compositions with improved bioavailability.
ZA978178B (en) Composition.
ZA987489B (en) Fungicidal 2-methoxybenzophenones.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA979199B (en) Aminothiophenecarboxamides.
ZA975261B (en) Composition.
HK1016976A1 (en) Resorcinyl-triazine.
ZA977206B (en) Arylalkanoylpyridazines.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA973629B (en) Pesticidal composition.
ZA973344B (en) Antifungal compositions.
ZA977207B (en) Amino-lipopeptide antifungal agents.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA974428B (en) Antifungal composition with enhanced bioavailability.
ZA9811502B (en) Novel composition.
AU5844498A (en) Antifungal composition
ZA971638B (en) Microbicidal composition.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA976022B (en) Cycloalkano-pyridines.
ZA972516B (en) Rodenticide.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA977937B (en) Insecticidal composition.